lamivudine has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxi, SM; Choden, T; Desai, M; Dorjee, K; Hubbard, AE; Reingold, AL | 1 |
| Achenbach, CJ; Murphy, RL; Scarsi, KK | 1 |
1 review(s) available for lamivudine and Myocardial Infarction
| Article | Year |
|---|---|
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.
Topics: Anti-HIV Agents; Area Under Curve; Clinical Trials as Topic; Dideoxynucleosides; Drug Combinations; Drug Interactions; Half-Life; HIV Infections; Humans; Lamivudine; Metabolic Clearance Rate; Myocardial Infarction | 2010 |
1 other study(ies) available for lamivudine and Myocardial Infarction
| Article | Year |
|---|---|
Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; HIV Infections; HIV-1; Humans; Lamivudine; Myocardial Infarction; Tenofovir; United States | 2021 |